HR 5526 · 119th CongressIn Committeecongress.gov ↗

Biosimilar Red Tape Elimination Act

Share Share Share

What this bill does

AI plain-language summary

This bill appears to concern reducing regulatory requirements or bureaucratic processes related to biosimilar drugs. No official summary is available for this bill.

Sponsor

Rep. Pfluger, August [R-TX-11]

R

Introduced

September 19, 2025

Policy Area

Health

Your Vote

Discussion (0)

Explain what is at stake in this bill.

Sign in to join the discussion.

No comments yet. Be the first.